Globus Medical Overview
Globus Medical Target Price
Analysts' 12-month price predictions for GMED.
Share Price
$64.72
Average Target Price
$60.00
7.3% downside
7.3% downside1 analysts in the last 4 months
High: $60 | Low: $60
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-18 | BTIGRyan Zimmerman | $60 | 7.3% downside |  |
| 2023-09-19 | Stifel NicolausMathew Blackman | $61 | 5.7% downside | |
| 2023-01-06 | Morgan Stanley | $78 |  20.5% upside | |
| 2022-12-20 | Truist Financial | $85 | 31.3% upside | |
| 2022-12-12 | Wells Fargo | $82 | 26.7% upside | |
| 2022-08-05 | Piper Sandler | $75 | 15.9% upside | |
| 2022-07-20 | Truist Financial | $71 | 9.7% upside | |
| 2022-07-15 | Morgan Stanley | $62 | 4.2% downside | |
| 2022-05-12 | Morgan Stanley | $68 | 5.1% upside | |
| 2022-05-11 | RBC Capital | $73 | 12.8% upside | |
| 2022-05-11 | Needham | $71 | 9.7% upside | |
| 2021-12-13 | Bank of America SecuritiesCraig Bijou | $80 | 23.6% upside | |
| 2021-08-05 | Leerink PartnersRichard Newitter | $96 | 48.3% upside | |
| 2021-08-05 | CitigroupMatthew Henriksson | $93 | 43.7% upside | |
| 2021-08-05 | Canaccord GenuityKyle Rose | $90 | 39.1% upside | |
| 2021-05-05 | OppenheimerSteven Lichtman | $79 | 22.1% upside | |